Page 2 - Alzheimer’s

Link between retinal changes and Alzheimer's allows early tracking, therapy

Macquarie University study finds protein markers in the eye that mirror changes in the brain, confirming researchers' long-standing suspicion about the existence of such a link

More diagnostic tools for early detection of Alzheimer's underway: Report

With advancements in medical technology, novel diagnostic tools are emerging to facilitate early and accurate detection of Alzheimer's disease, according to a report on Friday

Traffic-related air pollution can cause Alzheimer's disease: Research

Memory loss, cognitive decline, and the activation of neural pathways linked to the start of Alzheimer's disease were shown to be caused by exposure to air pollution caused by traffic in Irvine

Women are more likely to get Alzheimer's disease, find researchers

Scientists discover a clue to molecular origin of Alzheimer's disease, which may explain why women are more susceptible to the condition

Alzheimer's drug trial shown to slow cognitive decline, says report

A new drug, lecanemab, has been found to slow down cognitive decline in Alzheimer's patients, according to a study that could lead to new treatments for the neurodegenerative disease. The study results were presented at the 15th Clinical Trials on Alzheimer's Disease (CTAD) Conference in San Francisco, US, on November 29. The study is also published in the New England Journal of Medicine. Amyloid-clearing and cognitive decline-slowing drug lecanemab, which is poised for FDA approval early next year, will be a positive step in the treatment of Alzheimer's, the study said. Alzheimer's is a complex disease with multiple underlying causes tied to the biology of aging, therefore, the Alzheimer's Drug Discovery Foundation (ADDF) has long held that a combination drug approach is needed, the study said. Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. "Today's results show that lecanema

World's most expensive drug approved to treat hemophilia at $3.5 mn a dose

CSL Behring's Hemgenix, administered just once, cut the number of bleeding events expected over the course of a year by 54%, a key study of the therapy found

Chris Hemsworth to take break from acting, at risk of getting Alzheimer's

Hollywood star Chris Hemsworth says he will take "time off" from acting after learning he has a genetic predisposition to Alzheimer's disease. The Australian actor, who is currently promoting his Disney+ docu-series "Limitless", told the Vanity Fair magazine that after doing an episode on death and mortality, he realised the importance of spending time with his family. "I want to sit and be in this space with a greater sense of stillness and gratitude. And then you start talking about kids and family and going, 'Oh my God, they're getting older, they're growing up, and I keep slapping another movie on top of another movie.' "Before you know it, they're 18, and they've moved out of the house, and I missed the window. It really triggered something in me to want to take some time off. And since we finished the show, I've been completing the things I was already contracted to do," Hemsworth said. The 39-year-old actor shares daughter India, 10, and eight-year-old twin sons Tristan and

Suven starts Phase 3 trial for first home-grown Alzheimer's drug

Clinical trial randomisation is the process of assigning patients by chance to groups that receive different treatments

The woes of ageing India and rising Alzheimer's cases

India is gradually ageing and the risk of Alzheimer’s disease affecting more of its elderly population is on the rise. Watch the video to learn about the woes of India and rising Alzheimer's cases >

Alzheimer's-related deaths in India increased 5 times in 30 years

Lancet study: Alzheimer's and other dementias claimed 129,000 lives in 2019

India's Alzheimer's burden is growing, but treatment still out of reach

Doctors say there is no national-level policy programme for Alzheimer's and the bulk of the family expenditure on health is on people in their productive ages

Alzheimer's progression slows by 27% in large-scale drug trial

Lecanemab reduced the pace of cognitive decline in people with early disease by 27% over 18 months when compared with a placebo, meeting the main goal of the trial

Repeated infections increase risk of neurodegenerative diseases: Study

Infections treated with speciality hospital care in early and mid-life are associated with an increased subsequent risk of Alzheimer's (AD) and Parkinson's diseases (PD), according to a new study.

Breakthrough Covid infection more likely in cancer, Alzheimer's patients

Breakthrough Covid-19 cases resulting in infections, hospitalisations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies.

Degeneration of neurons makes Alzheimer's patients drowsy: Study

According to a recent study, the drowsiness that many Alzheimer's patients experience are caused not by a lack of sleep, but rather by the degeneration of a type of neuron that keeps us awake

US govt programme to cover Biogen Alzheimer's drug only for trial patients

The FDA approved the drug in June despite its committee of outside experts voting in November 2020 that the drug should not be approved.

Drugmaker Biogen cuts the price tag on its Alzheimer's medicine in half

Biogen said that it will cut the wholesale acquisition cost of the drug by about 50 per cent next month

Alzheimer's Day 2021: What causes it? What we know, don't know and suspect

Alzheimer's Day 2021: A hallmark of Alzheimer's disease is gradual deterioration of memory. Here's all you need to know about the disease on World Alzheimer's Day 2021

Alzheimer's Day 2021: What types of memories are forgotten in this disease

World Alzheimer's Day 2021: Typically, Alzheimer's disease is associated with degeneration of brain cells (neurons) and related dementia that affects memory.

Alzheimer's disease: hyperbaric oxygen proposed as treatment in new study

Scientists in Israel have shown that a type of oxygen therapy can stop new plaques forming and even remove existing plaques in mice with Alzheimer's